Director, Bioanalytical and Biomarker Development
Recursion Pharmaceuticals
Salt Lake City, Utah
Jennifer is the Director of Bioanalytical and Biomarker Development at Recursion Pharmaceuticals. In this role, she supports clinical development through the management of all bioanalytical and biomarker services. She brings strengths in both organic chemistry and analytical method development to her position. At Stanford University, she received a Ph.D. in synthethic organic chemistry with Barry M. Trost. Positions in medicinal and process development chemistry at Eli Lilly and Company, Schering-Plough and ZDye, LLC utilized this skill set while also putting her at an interface with analytical teams and analytical method development. Her position at Phenomenex chromatography further honed her approaches to LC/MS method development while exposing her to a great range of methods across regulated and non-regulated pharmaceutical, food, environmental, cosmetic and petroleum industries. At AIT Bioscence, Jennifer supported bioanalysis for a large variety of pre-clinical and clinical trials. While at Recursion Pharmaceuticals, Jennifer continues to contribute to the scientific discussion through peer-reviewed journal contributions as well as presenting and volunteering for organizations such as AAPS.
Disclosure information not submitted.
Speaker Spotlight: Automation in Regulated Bioanalysis
Monday, October 21, 2024
2:30 PM – 3:30 PM MT
Speaker Spotlight: The Evolution of BioTech into TechBio
Tuesday, October 22, 2024
9:30 AM – 10:30 AM MT